Closing the Rx Gap Between Oncology Guidelines and Practice
Originally published by our sister publication Specialty Pharmacy ContinuumBy Marcus A. BanksPersonalized oncology care depends on timely biomarker and genetic testing to guide treatment, but those tests are not always performed when patients need them, speakers said at Asembia’s AXS26 Summit, in Las Vegas. For specialty pharmacists, that gap represents both a patient-care challenge and a call to action: Help identify access barriers, reinforce appropriate testing and treatment pathways, a
Read more »